XML 33 R20.htm IDEA: XBRL DOCUMENT v3.21.2
RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS (Tables)
4 Months Ended
Dec. 31, 2020
RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS  
Summarizes the effect of the correction on each financial statement line item

 

 

 

 

 

 

 

 

 

 

 

    

As

    

 

 

    

 

 

 

 

Previously

 

 

 

 

As

 

 

Reported

 

Adjustments

 

Restated

Balance sheet as of November 10, 2020 (audited)

 

 

  

 

 

  

 

 

  

Warrant Liability

 

$

 —

 

$

22,547,500

 

$

22,547,500

Class A Common Stock Subject to Possible Redemption

 

 

212,828,471

 

 

(22,547,500)

 

 

190,280,971

Class A Common Stock

 

 

113

 

 

222

 

 

335

Additional Paid-in Capital

 

 

4,999,970

 

 

1,303,608

 

 

6,303,578

Accumulated Deficit

 

 

(712)

 

 

(1,303,830)

 

 

(1,304,542)

 

 

 

 

 

 

 

 

 

 

Balance sheet as of December 31, 2020 (audited)

 

 

  

 

 

  

 

 

  

Warrant Liability

 

$

 —

 

$

27,455,162

 

$

27,455,162

Class A Common Stock Subject to Possible Redemption

 

 

224,050,680

 

 

(27,455,162)

 

 

195,595,518

Common Stock

 

 

119

 

 

270

 

 

389

Additional Paid-in Capital

 

 

5,164,409

 

 

5,175,301

 

 

10,339,710

Accumulated Deficit

 

 

(165,106)

 

 

(5,175,571)

 

 

(5,340,677)

Stockholders’ Equity

 

 

5,000,001

 

 

 4

 

 

5,000,005

 

 

 

 

 

 

 

 

 

 

Statement of Operations for the Period from August 21, 2020 (inception) to December 31, 2020 (audited)

 

 

  

 

 

  

 

 

  

Change in fair value of warrant liability

 

$

 —

 

$

(4,460,862)

 

$

(4,460,862)

Transaction costs associated with Initial Public Offering

 

 

 —

 

 

(714,710)

 

 

(714,710)

Net loss

 

 

(165,106)

 

 

(5,175,572)

 

 

(5,340,678)

Weighted average shares outstanding, Common stock subject to possible redemption

 

 

21,828,647

 

 

(2,303,331)

 

 

19,525,316

Basic and diluted net income per share, Common stock subject to possible redemption

 

 

0.00

 

 

 —

 

 

0.00

Weighted average shares outstanding, Common stock

 

 

6,078,552

 

 

939,759

 

 

7,018,311

Basic and diluted net loss per share, Common stock

 

 

(0.03)

 

 

(0.73)

 

 

(0.76)

 

 

 

 

 

 

 

 

 

 

Cash Flow Statement for the Period from August 21, 2020 (inception) to December 31, 2020 (audited)

 

 

  

 

 

  

 

 

  

Net loss

 

 

(165,106)

 

 

(5,175,572)

 

 

(5,340,678)

Change in fair value of warrant liability

 

$

 —

 

$

(4,460,862)

 

$

(4,460,862)

Transaction costs associated with Initial Public Offering

 

 

 —

 

 

(714,710)

 

 

(714,710)

Initial classification of Class A common stock subject to possible redemption

 

 

224,215,068

 

 

(23,644,544)

 

 

200,570,524

Change in value of Class A common stock subject to possible redemption

 

 

(164,388)

 

 

(3,810,618)

 

 

(3,975,006)

 


 

 

 

 

 

 

 

 

 

 

 

 

As

 

 

 

 

 

 

 

 

Previously

 

 

 

 

As

 

    

Restated

    

Adjustment

    

Restated

Balance Sheet as of November 10, 2020 (audited)

 

 

  

 

 

  

 

 

  

Common stock subject to possible redemption

 

$

190,280,971

 

$

34,119,029

 

$

224,400,000

Common stock

 

$

335

 

$

(335)

 

$

Additional paid-in capital

 

$

6,303,578

 

$

(6,303,578)

 

$

Accumulated deficit

 

$

(1,304,542)

 

$

(27,815,116)

 

$

(29,119,658)

Total Stockholders’ Equity (Deficit)

 

$

5,000,004

 

$

(34,119,029)

 

$

(29,119,025)

 

 

 

 

 

 

 

 

 

 

Balance Sheet as of December 31, 2020 (audited)

 

 

  

 

 

  

 

 

  

Common stock subject to possible redemption

 

$

196,595,514

 

$

39,595,686

 

$

236,191,200

Common stock

 

$

389

 

$

(389)

 

$

Additional paid-in capital

 

$

10,339,715

 

$

(10,339,715)

 

$

Accumulated deficit

 

$

(5,340,678)

 

$

(29,255,581)

 

$

(34,596,259)

Total Stockholders’ Equity (Deficit)

 

$

5,000,005

 

$

(39,595,684)

 

$

(34,595,681)

 

 

 

 

 

 

 

 

 

 

Statement of Changes in Stockholders’ Equity (Deficit) for the Period from August 21, 2020 (Inception) Through December 31, 2020 (Audited)

 

 

  

 

 

  

 

 

  

Sale of 23,156,000 Units, net of underwriting discounts and offering expenses

 

 

206,911,197

 

 

(206,911,197)

 

 

Common stock subject to redemption

 

 

196,595,514

 

 

(196,595,514)

 

 

Accretion for Class A common stock to redemption amount

 

 

 

 

(29,279,949)

 

 

(29,279,949)

 

 

 

 

 

 

 

 

 

 

Statement of Cash Flows for the Three Months Ended December 31, 2020 (Unaudited)

 

 

  

 

 

  

 

 

  

Initial classificiation of Class A common stock subject to possible redemption

 

 

224,215,068

 

 

11,976,132

 

 

236,191,200